EUVIMEDEUVIMED entdecken
Open Access

A Single-Dose Intranasal Combination Panebolavirus Vaccine

Delphine C Malherbe, J Brian Kimble, Caroline Atyeo, Stephanie Fischinger, Michelle Meyer, S Gabrielle Cody, Matthew Hyde, Galit Alter, Alexander Bukreyev iD

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Delphine C Malherbe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Ebola Vaccines, Hemorrhagic Fever, Ebola, Ebolavirus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ebolaviruses Ebola (EBOV), Sudan (SUDV), and Bundibugyo (BDBV) cause severe human disease, which may be accompanied by hemorrhagic syndrome, with high case fatality rates. Monovalent vaccines do not offer cross-protection against these viruses whose endemic areas overlap. Therefore, development of a panebolavirus vaccine is a priority. As a vaccine vector, human parainfluenza virus type 3 (HPIV3) has the advantages of needle-free administration and induction of both systemic and local mucosal antibody responses in the respiratory tract.

Methods

To minimize the antivector immunity, genes encoding the HPIV3 envelope proteins F and HN were removed from the vaccine constructs, resulting in expression of only the ebolavirus envelope protein—glycoprotein. These second-generation vaccine constructs were used to develop a combination vaccine against EBOV, SUDV, and BDBV.

Results

A single intranasal vaccination of guinea pigs or ferrets with the trivalent combination vaccine elicited humoral responses to each of the targeted ebolaviruses, including binding and neutralizing antibodies, as well as Fc-mediated effector functions. This vaccine protected animals from death and disease caused by lethal challenges with EBOV, SUDV, or BDBV.

Conclusions

The combination vaccine elicited protection that was comparable to that induced by the monovalent vaccines, thus demonstrating the value of this combination trivalent vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ebola VaccinesHemorrhagic Fever, EbolaEbolavirusAnimalsHumansGuinea PigsAntibodies, ViralFerretsAntibodies, NeutralizingVaccines, Combined

Stichwörter der Autor:innen

Ebola virusintranasal vaccinationvaccine

Substanzen

Antibodies, ViralEbola VaccinesAntibodies, NeutralizingVaccines, Combined

Autor:innen und Institutionen

  • Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Galveston National Laboratory, Galveston, Texas, USA.
  • Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

ORCID-Profile: Alexander Bukreyev

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Malherbe, D. C., Kimble, J. B., Atyeo, C., Fischinger, S., Meyer, M., Cody, S. G., Hyde, M., Alter, G., & Bukreyev, A. (2023). A Single-Dose Intranasal Combination Panebolavirus Vaccine. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad266

Vancouver

Malherbe DC, Kimble JB, Atyeo C, Fischinger S, Meyer M, Cody SG, et al. A Single-Dose Intranasal Combination Panebolavirus Vaccine. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad266

BibTeX
@article{Malherbe2023,
  author = {Malherbe, Delphine C and Kimble, J Brian and Atyeo, Caroline and Fischinger, Stephanie and Meyer, Michelle and Cody, S Gabrielle and Hyde, Matthew and Alter, Galit and Bukreyev, Alexander},
  title = {A Single-Dose Intranasal Combination Panebolavirus Vaccine},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad266}
}
Kostenlos starten →